Daré Bioscience’s $22 Million Non-Dilutive Strategic Royalty Financing

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Daré Bioscience, Inc. on the transaction, and Gibson, Dunn & Crutcher advised XOMA (US) LLC.Daré Bioscience, Inc. (NASDAQ:…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now